| ADR Ontology |
| ADR Term |
Hyperparathyroidism primary |
| ADR ID |
BADD_A02135 |
| ADR Hierarchy |
|
| Description |
A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION. [MeSH] |
| MedDRA Code |
10020707 |
| MeSH ID |
D049950
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Hyperparathyroidism primary | Primary hyperparathyroidism | Hyperparathyroidism, Primary | Hyperparathyroidisms, Primary | Primary Hyperparathyroidisms | Primary Hyperparathyroidism |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
